As antibodies do not normally cross the blood–brain barrier, the detection of WNV IgM in the CSF is a marker of neuroinvasive disease, as IgM antibodies can only permeate the blood–brain barrier due to inflammation [4]. This evidence concerns the gene CD40LG and glycogen storage disease VI.